Wolters Kluwer Health
may email you for journal alerts and information, but is committed
to maintaining your privacy and will not share your personal information without
your express consent. For more information, please refer to our Privacy Policy.

Creatine Monohydrate Use Among Elite Australian Power Lifters

ABSTRACTA self-administered questionnaire examining creatine monohydrate (Cr·H2O) use was sent to 82 elite Australian power lifters, of which 61% (n = 50) questionnaires were returned. Ninety-six percent of respondents (n = 48) were aware of Cr·H2Q. Seventy-four percent (n = 37) identified themselves as current or former users, and 26% (n = 13) as nonusers. Power lifters agreed that Cr·H2O improved the quality of their training and competitive performance. An increase in body mass was the most common side effect. Seventy percent of users (n = 26) reported a cyclic method of intake, 14% (n = 5) reported a regular intake, and 16% (n = 6) reported an intermittent intake. Cyclic users displayed a median of 5.8 and 38.5 days for the loading and maintenance phases, respectively. During the loading phase, cyclic users reported a median loading dose of 5 g. During the maintenance phase, cyclic users reported a mean of 6.0 ± 2.4 g per dose. This study has found that awareness and use of Cr·H2O is widespread among elite Australian power lifters and that most use a cyclic method of Cr·H2O administration.

A self-administered questionnaire examining creatine monohydrate (Cr·H2O) use was sent to 82 elite Australian power lifters, of which 61% (n = 50) questionnaires were returned. Ninety-six percent of respondents (n = 48) were aware of Cr·H2Q. Seventy-four percent (n = 37) identified themselves as current or former users, and 26% (n = 13) as nonusers. Power lifters agreed that Cr·H2O improved the quality of their training and competitive performance. An increase in body mass was the most common side effect. Seventy percent of users (n = 26) reported a cyclic method of intake, 14% (n = 5) reported a regular intake, and 16% (n = 6) reported an intermittent intake. Cyclic users displayed a median of 5.8 and 38.5 days for the loading and maintenance phases, respectively. During the loading phase, cyclic users reported a median loading dose of 5 g. During the maintenance phase, cyclic users reported a mean of 6.0 ± 2.4 g per dose. This study has found that awareness and use of Cr·H2O is widespread among elite Australian power lifters and that most use a cyclic method of Cr·H2O administration.